Skip to main content
. Author manuscript; available in PMC: 2010 Jun 22.
Published in final edited form as: Free Radic Biol Med. 2008 Jan 5;44(7):1433–1442. doi: 10.1016/j.freeradbiomed.2007.12.035

Fig. 6.

Fig. 6

The effect of SCH58261 treatment on cardiac p47phox phosphorylation and MAPK activation. (A) Top panel: p47phox was immunoprecipitated down and detected by a phospho-serine-specific monoclonal antibody. Total p47phox was detected in parallel as loading controls. (B) ERK1/2, p38MAPK, and JNK phosphorylation detected by phospho-specific monoclonal antibodies. (C) Protein bands were quantified densitometrically and the results were normalised to the total protein levels of these molecules in the same samples and expressed as arbitrary units. n=12 hearts. *P<0.05 for indicated value versus vehicle control.